Tag:
Juventas Therapeutics
Latest Headlines
Latest Headlines
Juventas plans $25M venture round in wake of PhI success
The CEO of Juventas Therapeutics, a spinoff of the Cleveland Clinic, says that now that the company has wrapped a successful Phase I trial of its lead stem cell therapy, it plans to raise $25 million
